396 related articles for article (PubMed ID: 31476962)
1. Circulating Monocyte Chemoattractant Protein-1 and Risk of Stroke: Meta-Analysis of Population-Based Studies Involving 17 180 Individuals.
Georgakis MK; Malik R; Björkbacka H; Pana TA; Demissie S; Ayers C; Elhadad MA; Fornage M; Beiser AS; Benjamin EJ; Boekholdt SM; Engström G; Herder C; Hoogeveen RC; Koenig W; Melander O; Orho-Melander M; Schiopu A; Söderholm M; Wareham N; Ballantyne CM; Peters A; Seshadri S; Myint PK; Nilsson J; de Lemos JA; Dichgans M
Circ Res; 2019 Sep; 125(8):773-782. PubMed ID: 31476962
[No Abstract] [Full Text] [Related]
2. Association of Circulating Monocyte Chemoattractant Protein-1 Levels With Cardiovascular Mortality: A Meta-analysis of Population-Based Studies.
Georgakis MK; de Lemos JA; Ayers C; Wang B; Björkbacka H; Pana TA; Thorand B; Sun C; Fani L; Malik R; Dupuis J; Engström G; Orho-Melander M; Melander O; Boekholdt SM; Zierer A; Elhadad MA; Koenig W; Herder C; Hoogeveen RC; Kavousi M; Ballantyne CM; Peters A; Myint PK; Nilsson J; Benjamin EJ; Dichgans M
JAMA Cardiol; 2021 May; 6(5):587-592. PubMed ID: 33146689
[TBL] [Abstract][Full Text] [Related]
3. Genetically Determined Levels of Circulating Cytokines and Risk of Stroke.
Georgakis MK; Gill D; Rannikmäe K; Traylor M; Anderson CD; Lee JM; Kamatani Y; Hopewell JC; Worrall BB; Bernhagen J; Sudlow CLM; Malik R; Dichgans M
Circulation; 2019 Jan; 139(2):256-268. PubMed ID: 30586705
[TBL] [Abstract][Full Text] [Related]
4. Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis.
Deo R; Khera A; McGuire DK; Murphy SA; Meo Neto Jde P; Morrow DA; de Lemos JA
J Am Coll Cardiol; 2004 Nov; 44(9):1812-8. PubMed ID: 15519012
[TBL] [Abstract][Full Text] [Related]
5. Association between plasma monocyte chemoattractant protein-1 concentration and cardiovascular disease mortality in middle-aged diabetic and nondiabetic individuals.
Piemonti L; Calori G; Lattuada G; Mercalli A; Ragogna F; Garancini MP; Ruotolo G; Luzi L; Perseghin G
Diabetes Care; 2009 Nov; 32(11):2105-10. PubMed ID: 19641159
[TBL] [Abstract][Full Text] [Related]
6. Circulating Interleukin-6 Levels and Incident Ischemic Stroke: A Systematic Review and Meta-analysis of Prospective Studies.
Papadopoulos A; Palaiopanos K; Björkbacka H; Peters A; de Lemos JA; Seshadri S; Dichgans M; Georgakis MK
Neurology; 2022 Mar; 98(10):e1002-e1012. PubMed ID: 34969940
[TBL] [Abstract][Full Text] [Related]
7. Association of Monocyte Chemoattractant Protein-1 with Death and Atherosclerotic Events in Chronic Kidney Disease.
Gregg LP; Tio MC; Li X; Adams-Huet B; de Lemos JA; Hedayati SS
Am J Nephrol; 2018; 47(6):395-405. PubMed ID: 29874658
[TBL] [Abstract][Full Text] [Related]
8. Associations of Adiposity, Circulating Protein Biomarkers, and Risk of Major Vascular Diseases.
Pang Y; Kartsonaki C; Lv J; Fairhurst-Hunter Z; Millwood IY; Yu C; Guo Y; Chen Y; Bian Z; Yang L; Chen J; Clarke R; Walters RG; Holmes MV; Li L; Chen Z
JAMA Cardiol; 2021 Mar; 6(3):276-286. PubMed ID: 33263724
[TBL] [Abstract][Full Text] [Related]
9. Novel hemostatic factor levels and risk of ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study.
Suri MF; Yamagishi K; Aleksic N; Hannan PJ; Folsom AR
Cerebrovasc Dis; 2010; 29(5):497-502. PubMed ID: 20299790
[TBL] [Abstract][Full Text] [Related]
10. Monocyte chemotactic protein-1 as a potential biomarker for early anti-thrombotic therapy after ischemic stroke.
Worthmann H; Dengler R; Schumacher H; Schwartz A; Eisert WG; Lichtinghagen R; Weissenborn K
Int J Mol Sci; 2012; 13(7):8670-8678. PubMed ID: 22942727
[TBL] [Abstract][Full Text] [Related]
11. Plasma MCP-1 level and risk for peripheral arterial disease and incident coronary heart disease: Atherosclerosis Risk in Communities study.
Hoogeveen RC; Morrison A; Boerwinkle E; Miles JS; Rhodes CE; Sharrett AR; Ballantyne CM
Atherosclerosis; 2005 Dec; 183(2):301-7. PubMed ID: 16285993
[TBL] [Abstract][Full Text] [Related]
12. Circulating biomarkers and incident ischemic stroke in the Framingham Offspring Study.
Shoamanesh A; Preis SR; Beiser AS; Kase CS; Wolf PA; Vasan RS; Benjamin EJ; Seshadri S; Romero JR
Neurology; 2016 Sep; 87(12):1206-11. PubMed ID: 27558379
[TBL] [Abstract][Full Text] [Related]
13. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
[TBL] [Abstract][Full Text] [Related]
14. Plasma natriuretic peptides and incidence of subtypes of ischemic stroke.
Berntsson J; Zia E; Borné Y; Melander O; Hedblad B; Engström G
Cerebrovasc Dis; 2014; 37(6):444-50. PubMed ID: 25060145
[TBL] [Abstract][Full Text] [Related]
15. Omega-3 Fatty Acids and Incident Ischemic Stroke and Its Atherothrombotic and Cardioembolic Subtypes in 3 US Cohorts.
Saber H; Yakoob MY; Shi P; Longstreth WT; Lemaitre RN; Siscovick D; Rexrode KM; Willett WC; Mozaffarian D
Stroke; 2017 Oct; 48(10):2678-2685. PubMed ID: 28830976
[TBL] [Abstract][Full Text] [Related]
16. Association of HIV viral load with monocyte chemoattractant protein-1 and atherosclerosis burden measured by magnetic resonance imaging.
Floris-Moore M; Fayad ZA; Berman JW; Mani V; Schoenbaum EE; Klein RS; Weinshelbaum KB; Fuster V; Howard AA; Lo Y; Schecter AD
AIDS; 2009 May; 23(8):941-9. PubMed ID: 19318907
[TBL] [Abstract][Full Text] [Related]
17. Monocytes and monocyte chemoattractant protein 1 (MCP-1) as early predictors of disease outcome in patients with cerebral ischemic stroke.
Bonifačić D; Toplak A; Benjak I; Tokmadžić VS; Lekić A; Kučić N
Wien Klin Wochenschr; 2016 Jan; 128(1-2):20-7. PubMed ID: 26542133
[TBL] [Abstract][Full Text] [Related]
18. Association between post-treatment circulating biomarkers of inflammation and survival among stage II-III colorectal cancer patients.
Hua X; Kratz M; Malen RC; Dai JY; Lindström S; Zheng Y; Newcomb PA
Br J Cancer; 2021 Sep; 125(6):806-815. PubMed ID: 34230610
[TBL] [Abstract][Full Text] [Related]
19. Association of circulating monocyte chemoattractant protein-1 levels with polycystic ovary syndrome: A meta-analysis.
Wu Z; Fang L; Li Y; Yan Y; Thakur A; Cheng JC; Sun YP
Am J Reprod Immunol; 2021 Aug; 86(2):e13407. PubMed ID: 33638245
[TBL] [Abstract][Full Text] [Related]
20. Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes.
de Lemos JA; Morrow DA; Sabatine MS; Murphy SA; Gibson CM; Antman EM; McCabe CH; Cannon CP; Braunwald E
Circulation; 2003 Feb; 107(5):690-5. PubMed ID: 12578870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
